Bioiberica has partnered with ByHealth, a supplier of vitamins and dietary supplements for the Chinese market, to develop a product for its joint health brand, Highflex. Formed in response to a growing market of physically active consumers seeking joint health solutions, the partnership aims to educate Chinese consumers about the benefits of collagen supplementation for joint health.
The Highflex type II collagen tablets incorporate Bioiberica’s native type II collagen ingredient, Collavant n2, which has reportedly been shown to improve knee discomfort and function. By partnering with Bioiberica, it says, ByHealth aims to capitalise on the ‘untapped potential’ of product development with native type II collagen and respond to the growing number of consumers looking to support their mobility with effective, convenient products across the country.
“China is a particularly interesting and dynamic territory in the global mobility market. It has a large ageing population and an emerging health-conscious younger generation, but collagen for joint health and mobility is a relatively new concept. There is therefore significant opportunity for brands looking to target Chinese consumers – especially if they educate them about the benefits of collagen beyond skin and beauty,” said Jaume Reguant, Healthcare Director at Bioiberica.
“We’re always seeking new collaborative partnerships with forward-thinking manufacturers that want to respond to emerging trends with the latest science and ingredient innovations. Bringing together ByHealth’s well-respected brand with our technical understanding has allowed both companies to reinforce its place in a fast-growing mobility market. We’re very proud to have been able to work so closely with the team at ByHealth to bring Highflex type II collagen tablets to life, and provide consumers with an effective solution that helps them achieve their health and wellness goals. We’re already in talks about further collaborations and excited to see how our partnership will grow.”
